临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (9): 660-.doi: 10.3969/j.issn.1000-3606.2021.09.005

• 新生儿疾病专栏 • 上一篇    下一篇

10q22.3q23.3 微缺失综合征合并高甲硫氨酸血症1 例报告并文献复习

王彦云,孙云,蒋涛   

  1. 南京医科大学附属妇产医院(南京市妇幼保健院)遗传医学中心(江苏南京 210004)
  • 出版日期:2021-09-15 发布日期:2021-09-03
  • 通讯作者: 蒋涛,孙云 电子信箱:jiangtao 6310 @ 126 .com,sunyun 80 @ 126 .com
  • 基金资助:
    国家重点研发计划项目(No. 2018 YFC 1002400);南京市卫生局课题(No.YKK 19118)

10q22.3-q23.2 deletion syndrome combined with hypermethioninemia: a case report and literature review

WANG Yanyun, SUN Yun, JIANG Tao   

  1. Center for Genetic Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004 , Jiangsu, China
  • Online:2021-09-15 Published:2021-09-03

摘要: 目的 探讨 10 q 22 . 3 q 23 . 3 微缺失综合征合并高甲硫氨酸血症的临床特征。方法 回顾分析 1 例 10 q 22 . 3 q 23 . 3微缺失综合征合并高甲硫氨酸血症患儿的临床资料。结果 患儿,男,特殊面容,额突出,鼻根低,眼距 宽,内眦赘皮,鼻头轻度上翘,人中浅,耳位低,余未见特殊异常。患儿于出生后72小时行串联质谱检测,蛋氨酸(MET) 306 . 02 μmol/L,召回复查 MET 升至 695 . 37 μmol/L。家系验证分析显示,患儿父亲为 10q22.3q23.2 微缺失综合 征,其缺失性CNV为自发变异(de novo),患儿母亲携带MAT 1 A基因c. 74 _ 75 delTG(p.Val 25 GlyfsX 7)杂合变异。患 儿最终确诊基因型为10 q 22 . 3q 23 . 2 deletion/c. 74 _ 75 delTG(p.Val 25 GlyfsX 7),为10 q 22 . 3 q 23 . 3微缺失综合征合 并高甲硫氨酸血症。确诊后患儿给予低蛋氨酸饮食联合康复训练,但患儿家属依从性差,MET控制在700 μmol/L 左 右,肝功能无异常,大运动发育无异常,语言发育迟缓。结论 报道1例10 q 22 . 3 q 23 . 3微缺失综合征合并高甲硫氨酸 血症病例。10 q 22 . 3 q 23 . 3 微缺失综合征外显不全,预后差异较大 ;MET 超过 600 μmol/L 需尽早予以低蛋氨酸饮食 治疗。

关键词: 10 q 22 . 3 q 23 . 2缺失综合征; 高甲硫氨酸血症; 串联质谱; 蛋氨酸

Abstract: Objective To explore the clinical features of 10 q 22 . 3 q 23 . 3 deletion syndrome combined with hypermethioninemia. Methods The clinical data of 10 q 22 . 3 q 23 . 3 deletion syndrome combined with hypermethioninemia in a child were retrospectively analyzed. Results A male child had special facial features, including prominent forehead, low base of the nose, ocular hypertelorism, epicanthus, slightly upturned apex nasi, moderately philtrum and low ear position, and no other special abnormalities were observed. The detection by tandem mass spectrometry found that methionine (MET) was 306. 02 μmol/L at 72 hours after birth, and rose to 695. 37 μmol/L at recall for examination. Familial verification analysis showed that the father of the child had 10q22.3q23.2 microdeletion syndrome, and the deletion CNV was de novo. The mother of the child carried a heterozygous variation of c. 74 _ 75 delTG (p.Val25GlyfsX7) in MAT1A gene. The final diagnosis genotype of the prohand was 10q22.3q23.2 deletion/c.74_75delTG (p.Val 25 GlyfsX 7 ), which leaded to 10 q 22 . 3 q 23 . 3 microdeletion syndrome with hypermethioninemia. After diagnosis, the proband was given low-methionine diet combined with rehabilitation training. The compliance of the families was so poor that the proband’s MET was controlled at around 700 μmol/L. There was no abnormality in liver function and large motor development. However, the language development was delayed. Conclusions The first case of 10 q 22 . 3 q 23 . 3 microdeletion syndrome combined with hypermethioninemia is reported. The prognosis of 10 q 22 . 3 q 23 . 3 microdeletion syndrome varies greatly because of the incomplete penetrance. When MET exceeds 600 μmol/L, low methionine diet is needed as soon as possible.

Key words: 10 q 22 . 3 -q 23 . 2 deletion syndrome; hypermethioninemia; tandem mass spectrometry; methionine